biostrategyanalytics.com
Vectura Plc: Evaluating the Effect of Product Success / Failure on Share Price
Torux Biotech together with Biostrategy Analytics have published an Analyst Report relating to Vectura Plc, a listed (LON:VEC) pharmaceutical company focused on Chronic Obstructive Pulmonary Diseas…